GXP PHARMAID ApS: Financial statements 2025
CVR: 29615861
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
GXP PHARMAID ApS (CVR 29615861) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 1,163,256 and a net result of DKK 122,320 compared with DKK 216,532 the year before. That is a decrease of 13.2% compared with the year before. Equity in the 2025 report amounted to DKK 1,218,531. The solvency ratio was 66.7%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 1,163,256
- Profit/Loss
- DKK 122,320
- Equity
- DKK 1,218,531
- Total Assets
- DKK 1,826,687
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 1.2 mio. | 122 t. | 1.2 mio. | 1 |
| 2024 | - | 1.3 mio. | 217 t. | 1.1 mio. | 1 |
| 2023 | - | 1.2 mio. | 513 t. | 880 t. | 1 |
| 2022 | - | 350 t. | -325 t. | 367 t. | 1 |
| 2021 | - | 363 t. | -504 t. | 691 t. | 2 |
Official annual report
How creditworthy is GXP PHARMAID ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
GXP PHARMAID ApS has published its annual report for 2024. Gross profit came to DKK 1,340,825, and the net result was DKK 216,532.
About GXP PHARMAID ApS
GXP PHARMAID ApS is a Danish company of the type Anpartsselskab based in Brønshøj, founded in 2006. The company is registered under the industry Anden teknisk rådgivning. The company was previously named Q-VIGILANCE ApS. The management consists of Nusret Asanovski. The company is owned by MAC ANDORBY ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 1,163,256 and a net result of DKK 122,320 compared with DKK 216,532 the year before. Equity in the 2025 report amounted to DKK 1,218,531.